Adams JP, Sweatt JD (2002), Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135-163.
Albeituni S, Stiban J (2019), Roles of ceramides and other sphingolipids in immune cell function and inflammation. Adv Exp Med Biol 1161:169-191.
Antunes M, Biala G (2012), The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93-110.
Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD (1998), The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1:602-609.
Barco A, Bailey CH, Kandel ER (2006), Common molecular mechanisms in explicit and implicit memory. J Neurochem 97:1520-1533.
Barreto-Chang OL, Dolmetsch RE (2009), Calcium imaging of cortical neurons using Fura-2 AM. J Vis Exp.
Bikman BT, Summers SA (2011), Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121:4222-4230.
Brewer GJ, Torricelli JR (2007), Isolation and culture of adult neurons and neurospheres. Nat Protoc 2:1490-1498.
Castro BM, Prieto M, Silva LC (2014), Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 54:53-67.
Castro K, Ntranos A, Amatruda M, Petracca M, Kosa P, Chen EY, Morstein J, Trauner D, et al. (2019), Body mass index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine 43:392-410.
Cavalli G, Heard E (2019), Advances in epigenetics link genetics to the environment and disease. Nature 571:489-499.
Collins BE, Greer CB, Coleman BC, Sweatt JD (2019), Histone H3 lysine K4 methylation and its role in learning and memory. Epigenetics Chromatin 12:7.
Cruciani-Guglielmacci C, López M, Campana M, le Stunff H (2017), Brain ceramide metabolism in the control of energy balance. Front Physiol 8:787.
Demirkan A, Isaacs A, Ugocsai P, Liebisch G, Struchalin M, Rudan I, Wilson JF, Pramstaller PP, et al. (2013), Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study. J Psychiatr Res 47:357-362.
Erondu NE, Kennedy MB (1985), Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain. J Neurosci 5:3270-3277.
Fernandes J, Arida RM, Gomez-Pinilla F (2017), Physical exercise as an epigenetic modulator of brain plasticity and cognition. Neurosci Biobehav Rev 80:443-456.
Filippov V, Song MA, Zhang K, Vinters HV, Tung S, Kirsch WM, Yang J, Duerksen-Hughes PJ (2012), Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J Alzheimers Dis 29:537-547.
Gallo FT, Katche C, Morici JF, Medina JH, Weisstaub NV (2018), Immediate early genes, memory and psychiatric disorders: Focus on c-Fos, Egr1 and Arc. Front Behav Neurosci 12:79.
Gandy KA, Canals D, Adada M, Wada M, Roddy P, Snider AJ, Hannun YA, Obeid LM (2013), Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins. Biochem J 449:661-672.
Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012), Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol 235:491-496.
Gomez-Larrauri A, Presa N, Dominguez-Herrera A, Ouro A, Trueba M, Gomez-Muñoz A (2020), Role of bioactive sphingolipids in physiology and pathology. Essays Biochem 64:579-589.
Gordon T (2009), The role of neurotrophic factors in nerve regeneration. Neurosurg Focus 26:E3.
Granzotto A, Bomba M, Castelli V, Navarra R, Massetti N, d'Aurora M, Onofrj M, Cicalini I, et al. (2019), Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence. Aging (Albany NY) 11:6336-6357.
Grynkiewicz G, Poenie M, Tsien RY (1985), A new generation of Ca2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260:3440-3450.
Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP (2019), Biomarkers for Alzheimer's Disease. Curr Alzheimer Res 16:518-528.
György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, et al. (2018), CRISPR/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer's disease. Mol Ther Nucleic Acids 11:429-440.
Haass. C, Lemere. CA, Capell. A, Citron. M, Seubert. P, Schenk. D, Lannfelt. L, Selkoe. DJ (1995), The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Medicine 1:1291–1296.
Hudmon A, Schulman H (2002), Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473-510.
Hussain G, Wang J, Rasul A, Anwar H, Imran A, Qasim M, Zafar S, Kamran SKS, et al. (2019), Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis 18:26.
Kaldun JC, Sprecher SG (2019), Initiated by CREB: resolving gene regulatory programs in learning and memory: switch in cofactors and transcription regulators between memory consolidation and maintenance network. Bioessays 41:e1900045.
Kayser BD, Prifti E, Lhomme M, Belda E, Dao MC, Aron-Wisnewsky J, Kontush A, Zucker JD, et al. (2019), Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism. Metabolomics 15:140.
Kim HJ, Hur SW, Park JB, Seo J, Shin JJ, Kim SY, Kim MH, Han DH, et al. (2019), Histone demethylase PHF2 activates CREB and promotes memory consolidation. EMBO Rep 20:e45907.
Knapp P, Bodnar L, Blachnio-Zabielska A, Swiderska M, Chabowski A (2017), Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer. Gynecol Oncol 147:139-144.
Komada M, Takao K, Miyakawa T (2008), Elevated plus maze for mice. Journal of Visualized Experiments.
Kraft ML (2017), Sphingolipid organization in the plasma membrane and the mechanisms that influence it. Cell and Developmental Biology.
Kurz J, Brunkhorst R, Foerch C, Blum L, Henke M, Gabriel L, Ulshofer T, Ferreiros N, et al. (2018), The relevance of ceramides and their synthesizing enzymes for multiple sclerosis. Clin Sci (Lond) 132:1963-1976.
Kurz J, Parnham MJ, Geisslinger G, Schiffmann S (2019), Ceramides as novel disease biomarkers. Trends Mol Med 25:20-32.
Lehmann S, Dumurgier J, Ayrignac X, Marelli C, Alcolea D, Ormaechea JF, Thouvenot E, Delaby C, et al. (2020), Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals. Alzheimers Res Ther 12:123.
Lewis AC, Wallington-Beddoe CT, Powell JA, Pitson SM (2018), Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies. Cell Death Discov 4:72.
Lisman J, Yasuda R, Raghavachari S (2012), Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci 13:169-182.
Mandal N, Grambergs R, Mondal K, Basu SK, Tahia F, Dagogo-Jack S (2021), Role of ceramides in the pathogenesis of diabetes mellitus and its complications. J Diabetes Complications 35:107734.
Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER (1996), Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678-1683.
Meilandt WJ, Yu GQ, Chin J, Roberson ED, Palop JJ, Wu T, Scearce-Levie K, Mucke L (2008), Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 28:5007-5017.
Mencarelli C, Martinez-Martinez P (2013), Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci 70:181-203.
Morris. R (1984), Developments of a water-maze procedure for studying spatial learning in the rat Journal of Neuroscience Methods 11:47-60
Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, et al. (2000), High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050-4058.
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992), A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1:345-347.
Muta Y, Matsuda M, Imajo M (2019), Divergent dynamics and functions of ERK MAP kinase signaling in development, homeostasis and cancer: Lessons from Fluorescent Bioimaging. Cancers (Basel) 11.
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, et al. (2003), Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
Olsen ASB, Færgeman NJ (2017), Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol 7.
Orsini M, Chateauvieux S, Rhim J, Gaigneaux A, Cheillan D, Christov C, Dicato M, Morceau F, et al. (2019), Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells. Cell Death Differ 26:1796-1812.
Pettit DL, Perlman S, Malinow R (1994), Potentiated transmission and prevention of further LTP by increased CaMKII activity in postsynaptic hippocampal slice neurons. Science 266:1881-1885.
Rohrbough J, Rushton E, Palanker L, Woodruff E, Matthies HJ, Acharya U, Acharya JK, Broadie K (2004), Ceramidase regulates synaptic vesicle exocytosis and trafficking. J Neurosci 24:7789-7803.
Rosenblum K, Futter M, Voss K, Erent M, Skehel PA, French P, Obosi L, Jones MW, et al. (2002), The role of extracellular regulated kinases I/II in late-phase long-term potentiation. J Neurosci 22:5432-5441.
Saha RN, Dudek SM (2013), Splitting hares and tortoises: a classification of neuronal immediate early gene transcription based on poised RNA polymerase II. Neuroscience 247:175-181.
Samuel VT, Shulman GI (2012), Mechanisms for insulin resistance: common threads and missing links. Cell 148:852-871.
Sandhoff R (2010), Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett 584:1907-1913.
Schaeffer. EL, Figueiro´. M, Gattaz WF (2011), Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. CLINICS 66:45-54.
Schwarz A, Rapaport E, Hirschberg K, Futerman AH (1995), A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J Biol Chem 270:10990-10998.
Sivanandam TM, Thakur MK (2012), Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev 36:1376-1381.
Sweatt JD (2013), The emerging field of neuroepigenetics. Neuron 80:624-632.
Tan-Chen S, Bourron O, Hajduch É (2020), Ceramides, crucial actors in the development of insulin resistance and type 2 diabetes. Med Sci (Paris) 36:497-503.
Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998), Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709-726.
Tobimatsu T, Fujisawa H (1989), Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem 264:17907-17912.
Turpin-Nolan SM, Bruning JC (2020), The role of ceramides in metabolic disorders: when size and localization matters. Nat Rev Endocrinol 16:224-233.
Vaquer CC, Suhaiman L, Pavarotti MA, De Blas GA, Belmonte SA (2020), Ceramide induces a multicomponent intracellular calcium increase triggering the acrosome secretion in human sperm. Biochim Biophys Acta Mol Cell Res 1867:118704.
Waddington CH (2012), The epigenotype. 1942. Int J Epidemiol 41:10-13.
Wang JH, Kelly PT (1995), Postsynaptic injection of CA2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 15:443-452.
Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ (2014), Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5:88.
Weller J, Budson A (2018), Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res 7.
Wigger L, Cruciani-Guglielmacci C, Nicolas A, Denom J, Fernandez N, Fumeron F, Marques-Vidal P, Ktorza A, et al. (2017), Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep 18:2269-2279.
Won J, Silva AJ (2008), Molecular and cellular mechanisms of memory allocation in neuronetworks. Neurobiol Learn Mem 89:285-292.
Yan X, Liu J, Ye Z, Huang J, He F, Xiao W, Hu X, Luo Z (2016), CaMKII-mediated CREB phosphorylation is involved in Ca2+-induced BDNF mRNA transcription and neurite outgrowth promoted by electrical stimulation. PLoS One 11:e0162784.
Zalcman G, Federman N, Romano A (2018), CaMKII isoforms in learning and memory: localization and function. Front Mol Neurosci 11:445.
孫筠雅 (2017)。幼年給予C16神經醯胺對於其成鼠後行為與記憶之影響 (Yun-Ya Sun (2017), Effect of C16-ceramide at early livesexposure on behavior/memory of adult mice.) 。